Trulieve Takes Major Step in Medical Marijuana Operations with New DEA Registrations
Trulieve Achieves Historic Milestone in Medical Marijuana Sector
On November 2, 2026, Trulieve Cannabis Corp., a prominent player in the U.S. medical cannabis industry, announced a groundbreaking achievement: they have received registrations from the U.S. Drug Enforcement Administration (DEA) for their state-licensed medical marijuana dispensaries. This milestone is part of the initial phase of federal registration which was started by the DEA, a significant step that aligns with the Attorney General's order issued in April of this year.
The movement towards federal registration signifies the beginning of a new framework for medical marijuana businesses in the U.S., allowing state-licensed dispensaries to operate under federal oversight while adhering to the regulations set forth in the Controlled Substances Act. This registration follows Trulieve's application for DEA approval which was prompted by the rescheduling of state-licensed medical marijuana, now classified as Schedule III under the Controlled Substances Act.
Trulieve's CEO, Kim Rivers, expressed enthusiasm about this pivotal moment.
Topics Consumer Products & Retail）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.